US to conduct major study into female genital mutilation

The Obama administration is to carry out a major study into female genital mutilation, in an effort to establish how many women are living with the consequences of FGM in the United States and how many girls are at risk.

The previous study was carried out in 1997 ,and new research is a central demand of a Guardian-backed campaign, led by Jaha Dukureh, which aims to put an end to the practice. Experts say that FGM, which involves the removal of a girl’s outer sexual organs and is often carried out without anaesthetic, often takes place during the summer holidays when American girls are taken out of the country for the purpose. A prevalence study is seen by campaigners as a vital first step in tackling FGM in the US.

Cathy Russell, the US ambassador for global women’s issues, confirmed that the study would be carried out by the US Department of Health and Human Services. Speaking to the Guardian at a major summit on FGM and child marriage in London, Russell praised the event for highlighting the issue. “This summit is important because it brings together government, civil society and activists who care and have been working on this issue,” she said.

FGM is carried out in 29 countries, and Unicef has estimated that more than 130 million women are living with the consequences, which include heavy bleeding, infections, infertility and death during childbirth. At least 228,000 American women and girls in the US are at risk of the practice, according to previous research from the African Women’s Health Center of the Brigham and Women’s Hospital, but the true number is thought to be much higher.

Young American women who were cut as girls and teenagers on trips back to their parents’ countries, a practice known as “vacation cutting”, told the Guardian that they had been left scarred physically and emotionally. Lesha, a 21-year-old from a southern state, said she and her sister were sent to Guinea when they were 11 and nine respectively. “I went to Africa to learn about my identity just to end up being scarred for life,” she said.

It also emerged that the Obama administration has set up a preliminary working group on FGM, as the first step to measuring the extent of the problem in the US and deciding how to tackle it. Russell said there had been an “initial meeting”‘, adding that the group would likely meet again to discuss developments at the London summit. “We’ve been engaged on this issue for a long time, and now we are trying it get a sense of where we stand”, she said.

It is understood the working group will look at how to fight FGM through education, and will also look at how to tackle “vacation cutting”.

Dukureh, whose petition calling for the new study on change.org has attracted more than 230,000 signatures, said the US had an opportunity to push for change in its own country and inspire change around the world.

“I’m so excited because this is exactly what we asked for,” she said. “It is a great success not just for me but for everyone who has fought for this. But it doesn’t stop here, we are not going away. This is a first step in ending FGM in the States, and where the US leads others might follow.”

Shelby Quast, policy advisor at Equality Now, which is working on the campaign, said the development was proof that people could make a difference.

“Civil society and survivors have raised their voices and the government has responded to that, she said. “This interagency meeting is a call from the president – it means he is bringing people together to talk about this issue. Now the Obama administration must ensure they get input from survivors like Jaha.”

US to conduct major study into female genital mutilation

New pharmaceutical conduct code under fire for not going far enough

Up to date drug company transparency suggestions will not deter doctors from accepting 1000′s of dollars which probably influence their prescribing habits, the peak entire body representing healthcare buyers says.

The Buyers Wellness Forum chief executive, Adam Stankevicius, stated pharmaceutical code of perform reforms proposed by the business physique Medicines Australia did not go far enough to give consumers confidence in the medicines they had been prescribed.

The guidelines will for the first time force pharmaceutical firms to disclose how much they invest on individual medical doctors, but people medical doctors can decide on to stay anonymous.

The expenditure on the unidentified medical professionals would rather be reported as a complete figure alongside the number of physicians it relates to. Buyers going on-line to find payments made to person medical professionals would be in a position to uncover only individuals who had consented to the data currently being made public.

“As a end result, senior medical authorities will nevertheless be in a position to receive tens of thousands of dollars in speakers’ costs, sponsored travel and other perks from a drug firm in return for providing talks about that company’s merchandise, without having these individual practitioner payments being disclosed,” Stankevicius said.

“Such undisclosed perks and remuneration undermine the independence of healthcare practitioners and the confidence of consumers in relation to medicines prescribing.”

Individuals should know if medical doctors were getting perks from the organizations that manufactured the medicines their doctors prescribed to them, he stated. “The code should need that practitioners forgo or repay payments from drug businesses if they are not ready to be named as recipients.

“One can reasonably question why the pharmaceutical sector would shell out millions of dollars a 12 months to Australia’s health care practitioners, if they are not expecting some return on that investment.”

But Medicines Australia chief executive Dr Brendan Shaw said the tips reflected best practice and had been created on the advice of the Australian privacy commissioner.

“[He] confirmed that it is best practice for a healthcare skilled to be asked for their consent just before personalized details relating to payments and transfers of value from pharmaceutical companies is published,” Shaw explained.

“Other legal authorities have suggested that businesses should obtain permission from doctors as a end result of commonwealth privacy legislation. We want to perform with the professions and health-related groups to inspire healthcare experts to supply consent.”

He mentioned relations in between pharmaceutical companies and healthcare experts had been suitable and useful, and that physicians ought to have no cause to want to hide that data.

“The pharmaceutical market and healthcare professional organisations previously every single encourage ethical collaboration, by way of self-regulatory codes of practice and guidelines,” he explained. “It is important that the two the business and healthcare professionals can demonstrate that these relationships are acceptable and ethical.”

The reforms would also allow up to $ 120 to be invested on a meal and beverages for personal medical doctors at occasions. “This greatest would only be suitable in exceptional circumstances, such as a dinner at a realized society conference with significant educational content material,” the recommendations say.

The transparency reforms have been submitted to the Australian Competitors and Client Commission for authorisation, a approach which will take up to 6 months.

If authorised they will get effect early next 12 months and apply to all Medicines Australia members, who provide virtually 90% of medicines accessible to patients.

New pharmaceutical conduct code under fire for not going far enough

The Brain And Conduct Investigation Basis: Producing A Big difference In Mental Overall health Study

On January 29, 2014, The Brain and Habits Analysis Basis, an organization which money cutting edge mental overall health investigation, announced important discoveries of 2013 funded by its NARSAD grants.

NARSAD is an acronym for the National Alliance for Analysis on Schizophrenia and Depression, the former identify for the now Brain and Behavior Analysis Foundation.

In accordance to Jeffrey Borenstein, M.D., President and CEO of the Brain and Behavior Analysis Basis, NARSAD grants support to fund investigation that gives new insight into the mysteries of the brain and prospective therapies for folks with depression, anxiousness, schizophrenia, PTSD and panic disorder.

NARSAD grants are targeted on three particular regions of attacking mental illness: standard investigation, new technologies, and subsequent generation therapies. Different amounts of economic assistance are supplied ranging from NARSAD Youthful Investigator Grants ($ 30,000/12 months), NARSAD Independent Investigator Grants  ($ 50,000/12 months) to NARSAD Distinguished Investigator Grants (a hundred,000/yr).

As Borenstein explains, the discoveries in standard analysis, new technology, next generation therapies and early intervention ranged from findings exhibiting the brain adds one,400 new neurons a day all through a person’s lifetime to the identification of brain activity that predicts regardless of whether people with serious depression will reply far better to antidepressants or psychotherapy.

The Brain &amp Habits Study Foundation, which funded 225 NARSAD Grants with $ 17 million in 2013, raises money to fund cutting-edge research for the comprehending, early detection, treatment method, prevention and remedy of psychological illness. It has awarded more than $ 300 million in NARSAD Research Grants to much more than 3,700 scientists about the world given that 1987. Since its inception, the Basis has been supported by private donations.

“We are getting into the golden age of brain research,” said Borenstein, noting that 2013 was a 12 months of extremely important advances.

“The best 10 findings of 2013”, Borenstein proclaims, “highlight the sort of scientific function that will support us recognize, treat and cure the psychological illnesses that have an effect on a single in four individuals.”

The mission at the Brain and Conduct Study Basis, however, is very exclusive in relation to funding psychological health analysis.

“We are in a position to fund cutting edge study that the government wouldn’t fund due to the fact typically they [the government] will fund research that already has some level of proof in location,” delivers Borenstein.

“We are ready to fund the preliminary perform that then permits our scientists that we fund to go on and get further federal funding”, explains Borenstein.  “The government is considerably more risk averse so the chance for actual advances comes from the sort of funding that we give.”

In accordance to Borenstein, right after monitoring individuals investigators who have achieved funding through the Brain and Behavior Investigation Foundation, “for every dollar that we have supplied in funding, they have eventually received on typical of 10 dollars from governmental funding subsequently.

As Borenstein sums up, “Because federal funding for study is steadily declining, personal funding is necessary to drive the type of substantial chance, large reward research that alterations lives.”

Borenstein theorizes that there has been a decline in federal funding for mental well being analysis in essence since “there is nevertheless prejudice towards psychological health issues, particularly how it is portrayed in the press making a stigma–which in some approaches impacts funding for psychological health”.

“The overall economic scenario and government tightening combine to make private funding far more crucial than ever”, additional Borenstein. “The paradox is that we are truly at a level in time of great opportunity.”

Borenstein concludes that “if we have been to then accelerate the amount of funding it would tremendously advance exactly where we are in terms of remedy for these conditions that impact so numerous people. “Everybody has a loved one particular or pal affected by a single of these situations.”

The Brain And Conduct Investigation Basis: Producing A Big difference In Mental Overall health Study